chevron_leftBack
T
As of 14 June 2026, TenNor Therapeutics Suzhou Ltd. Class H has a market cap of $1.34B USD, ranking #9052 globally and #2403 in China.
It ranks #770 in the Healthcare sector, and #150 in the Biotechnology industry.
Key Stats
Market Cap
$1.34BUSD
10.54B HKD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.8% | 35% | 35% | 35% | 35% | 35% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6872
ISIN: CNE100007KG6
Shares Out.:
Shares Outstanding:
51.753M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
202.00 HKD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHEK: 2269
|
$17.44B
1K%
136.71B HKD
|
25.3
|
|
SHEK: 1093
|
$12.2B
807%
95.58B HKD
|
22.1
|
|
SHE: 002422
|
$8.0B
495%
54.23B CNY
|
34.4
|
|
|
$7.33B
445%
49.69B CNY
|
-
|
||
SHEK: 1530
|
$7.08B
427%
55.5B HKD
|
5.8
|
|
SHE: 300347
|
$6.72B
400%
45.52B CNY
|
61.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
13K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
12K%
|
19.0
|
|
EBR: ARGX
|
$47.84B
3K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
3K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
3K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
3K%
33.71B CHF
|
37.2
|
chevron_leftBack